Waiting on the EMA decision is fine, but how do we get there in the interim? ASCO data is out, doesn't sound like much will be added at the presentation. NEO pre-clinical data out. HOT pre-clinical data out. Share price is still in the doldrums. If a deal is planned, it's going to have to be soon or dilution at these COMICAL levels is a definite risk. Isn't that what the share price is partially showing?
News 
Market Data 
Discover 
